Screening for functional neurological disorders by questionnaire by Shipston-Sharman, O. et al.
This is a repository copy of Screening for functional neurological disorders by 
questionnaire.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/143319/
Version: Accepted Version
Article:
Shipston-Sharman, O., Hoeritzauer, I., Edwards, M. et al. (3 more authors) (2019) 
Screening for functional neurological disorders by questionnaire. Journal of Psychosomatic
Research, 119. pp. 65-73. ISSN 0022-3999 
https://doi.org/10.1016/j.jpsychores.2019.02.005
Article available under the terms of the CC-BY-NC-ND licence 
(https://creativecommons.org/licenses/by-nc-nd/4.0/).
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Cover Letter 1 
Thank you for considering our paper for the Journal of Psychosomatic Research 2 
We describe the piloting and outcome of a new attempt to improving the pre-assessment 3 
diagnosis of functional neurological disorder by questionnaire. Although we were only in 4 
part successful, we think there are useful lessons here both about the nature of diagnosis in 5 
FND for researchers in FND and somatic symptoms in neurological populations, as well as 6 
promising leads for future studies.  7 
 8 
We state that: 9 
- All authors of this article had access to complete study data, are responsible for all 10 
contents of the article, and had authority over manuscript preparation and the decision 11 
to submit the manuscript for publication. 12 
- All authors have approved of the submission of the manuscript to the Journal of 13 
Psychosomatic Research. 14 
- The submitted manuscript is original and the data and conclusions presented have not 15 
been published or submitted in any other format. 16 
17 
dŚĞĚŝŶďƵƌŐŚEĞƵƌŽƐǇŵƉƚŽŵƐYƵĞƐƚŝŽŶŶĂŝƌĞ ?/ƐŝƚƉŽƐƐŝďůĞ18 
ƚŽƐĐƌĞĞŶĨŽƌĂĨƵŶĐƚŝŽŶĂůŶĞƵƌŽůŽŐŝĐĂů ĚŝƐŽƌĚĞƌƵƐŝŶŐ19 
ƋƵĞƐƚŝŽŶŶĂŝƌĞ ? 20 
 21 
Running head 22 
The Edinburgh Neurosymptoms Questionnaire  23 
 24 
Authors 25 
Oliver Shipston-Sharman1, Ingrid Hoeritzauer1, Mark Edwards2, Markus Reuber3, Alan 26 
Carson1,4, Jon Stone1. 27 
 28 
Author Affiliations 29 
1. Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom 30 
2. EĞƵƌŽƐĐŝĞŶĐĞZĞƐĞĂƌĐŚĞŶƚƌĞ ?/ŶƐƚŝƚƵƚĞŽĨDŽůĞĐƵůĂƌĂŶĚůŝŶŝĐĂů^ĐŝĞŶĐĞƐ ?^ƚ'ĞŽƌŐĞ ?Ɛ31 
University of London, London, United Kingdom 32 
3. Academic Neurology Unit, University of Sheffield, Royal Hallamshire Hospital, Glossop 33 
Road, Sheffield, S10 2JF, United Kingdom 34 
4. Scottish Neurobehavioural Rehabilitation Unit, Royal Edinburgh Hospital, Edinburgh, 35 
United Kingdom 36 
 37 
Corresponding Author 38 
Jon Stone; Jon.Stone@ed.ac.uk; The University of Edinburgh, Centre for Clinical Brain 39 
Sciences, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB 40 
 41 
Abstract: 248 words 42 
Article: 3969 words 43 
 44 
Target: Full length paper in The Journal of Psychosomatic Research 45 
 Word Limit: 4000 46 
 47 
 48 
Abstract  49 
Objective: Diagnostic screening for functional neurological disorders (FNDs) continues to 50 
pose a challenge. Simple symptom counts fail clearly to discriminate patients with FND but 51 
ƚŚĞƌĞŝƐŝŶĐƌĞĂƐŝŶŐƌĞĐŽŐŶŝƚŝŽŶŽĨ ‘ƉŽƐŝƚŝǀĞ ?ĨĞĂƚƵƌĞƐǁŚŝĐŚare useful diagnostically during 52 
face-to-face assessments. A self-completed screening questionnaire evaluating specific 53 
features of FNDs would be useful for screening purposes in clinical and research settings. 54 
Methods: The Edinburgh Neurosymptoms Questionnaire (ENS) is a 30-item survey of 55 
presence and nature of: blackouts, weakness, hemisensory syndrome, memory problems, 56 
tremor, pain, fatigue, globus, multiple medical problems, and operations constructed via 57 
literature review and expert consensus. We conducted a pilot of the ENS on new general 58 
neurology clinic attendees at a large regional neuroscience centre. Patients were grouped 59 
according to consultant neurologist impression ĂƐŚĂǀŝŶŐƐǇŵƉƚŽŵƐƚŚĂƚǁĞƌĞ ‘Not at 60 
Ăůů ? ? ?^ŽŵĞǁŚĂƚ ? ? ?>ĂƌŐĞůǇ ?or  ?ŽŵƉůĞƚĞůǇ ?ĚƵĞƚŽĂĨƵŶĐƚŝŽŶĂůĚŝƐŽƌĚĞƌ ? This classification 61 
was compared against ???? 62 
Results: Blackouts, weakness and memory questions provided reasonable diagnostic utility 63 
(AUROC = 0.94, 0.71, 0.74 respectively) in single symptom analysis. All other symptoms 64 
lacked discriminating features. A multivariate linear model with all symptoms predicted 65 
functional classification with moderate diagnostic utility (AUROC = 0.83), specificity of 0.97, 66 
sensitivity of 0.47. Pain and blackout scores provided the most accurate predictor of 67 
functional classification. 68 
Conclusion: The diagnosis of functional neurological disorders is difficult using unguided, 69 
self-reported questions. Our results suggest some promise however for differentiation of 70 
functional/dissociative blackouts from other causes, and further refinements could lead to a 71 
more useful clinical screening tool for other symptoms.  72 
 73 
Key Words: Functional Neurological Disorders, Symptom Count, Screening Questionnaire. 74 
 75 
Highlights: 76 
x A novel screening questionnaire for functional neurological disorders (FNDs). 77 
x Symptom counts provide no diagnostic utility in FNDs (AUC = 0.60). 78 
x Questions regarding positive features of FND provide modest utility (AUC = 0.83). 79 
Introduction 80 
Functional Neurological Disorders (FNDs) have historically been considered a common but 81 
challenging diagnosis (Nicholson et al. 2011) with a considerable impact on patient quality 82 
of life(Gelauff et al. 2014). Patients with symptoms without a structural cause comprise 30% 83 
of general neurology outpatients (Stone, A. Carson, et al. 2009) and between 16-34% of 84 
primary care attendees (Steinbrecher et al. 2011; de Waal et al. 2004; Haller et al. 2015). 85 
They are commonly undiagnosed (Murray et al. 2016; Dimsdale et al. 2013; Hamilton et al. 86 
2013; Leaver et al. 2016), over-investigated (Shaw & Creed 1991; Ring et al. 2005; Murray et 87 
al. 2016) and report poor clinical outcomes (Gelauff et al. 2014; Stone et al. 2003; Sharpe et 88 
al. 2010b). 89 
 90 
Although challenging for a variety of reasons (Murray et al. 2016), there is a growing 91 
body of literature describing the reliable diagnosis of FNDs if undertaken by clinicians 92 
appropriately trained in neurological assessment (Carson et al. 2003). It is a diagnosis based 93 
upon positive signs of inconsistency such as distractibility, entrainment etc. in the context of 94 
particular precipitants and psychosocial factors. Recent work (Daum et al. 2014; 95 
Schwingenschuh et al. 2016; Avbersek & Sisodiya 2010) has described the diagnostic value 96 
of a broad range of these signs, which in a pilot sample provided specificities and 97 
sensitivities of 100% and 95% respectively for a variety of functional disorders (Daum et al. 98 
2015). Consultation with a neurologist, although a reliable gold-standard, is financially 99 
prohibitive in large cohorts and scalable and accurate metrics of FND prevalence are lacking.  100 
 101 
There have been several self-report questionnaire approaches to assessing somatic 102 
symptoms (Zijlema et al. 2013), the Patient Health Questionnaire-15 (PHQ-15) (Kroenke et 103 
al. 2002) being perhaps the most widely used, including in the validation of DSM-5 cross-104 
cutting assessments (Regier et al. 2013; Narrow et al. 2013). These scores, although not 105 
initially intended for diagnostic use, have been applied (Van Ravesteijn et al. 2009; Körber et 106 
al. 2011) to the prediction of somatoform disorder with generally good sensitivities and 107 
specificities (78-80% and 59-71% respectively). In identifying FNDs specifically however, 108 
these tools fail to discriminate structural Žƌ “ŽƌŐĂŶŝĐ ? from functional neurological disorders 109 
and perform little better than chance when tested against clinical examination by a 110 
neurologist (Carson et al. 2014). 111 
 112 
Questionnaires using specific items can be diagnostic however. Self-reported 113 
features of transient loss of consciousness using an 86-item tool could predict with accuracy 114 
a diagnosis of syncope, psychogenic non-epileptic seizures and epilepsy with sensitivities 115 
and specificities ranging from 80-95% and 74-93% between diagnoses (Reuber et al. 2016). 116 
There have so far been no attempts to construct a short, self-report questionnaire for the 117 
prediction of a functional neurological disorders in general. Such a questionnaire could be 118 
used to increase pre-test probabilities of a functional disorder diagnosis and assist in 119 
epidemiological research. We would not expect that a questionnaire would, or should, 120 
replace clinical diagnosis. 121 
 122 
We therefore piloted a 30-item questionnaire that synthesised recognised diagnostic 123 
features of the neurological history in people with FND with the aim of exploring its 124 
diagnostic utility in screening for FND.  125 
 126 
Methods 127 
Patients 128 
We recruited from consecutive newly referred general neurology patients who attended a 129 
clinic appointment at the Department of Clinical Neurosciences, Western General Hospital, 130 
Edinburgh in a 4-week period between September and October 2017. Prospective 131 
participants were sent an information letter in the post with their appointment describing 132 
the aims and nature of the study. All patients were approached and consented in the 133 
waiting room. Patients were excluded if: they were under 16, they did not attend their 134 
appointment, they had cognitive impairment or insufficient English language skills to 135 
provide informed consent or completion of the survey. Ethical approval for the study was 136 
granted by South East Scotland Research Ethics Committee. 137 
Survey Design 138 
A literature review was undertaken to identify differentiating features of history which may 139 
distinguish those reporting symptoms of a functional rather than ĂŶ “ŽƌŐĂŶŝĐ ?ĚŝƐŽƌĚĞƌ. 140 
Expert consensus was used to construct a 30-item questionnaire (Appendix 1) from 141 
identified predictors which could be completed in under 10 minutes. We prioritised the 142 
most common symptoms presenting in outpatient neurology including: blackouts, pain, 143 
cognitive deficit, weakness, tremor, pain and fatigue. Features identified from the literature 144 
with evidence of diagnostic utility in these fields were: 145 
- Blackouts: Lying still or shaking; Episodes in a medical setting (McGonigal et al. 2002); 146 
More than two seizures lasting more than 10 minutes (Alessi et al. 2013; Plug & Reuber 147 
2009; Reuber et al. 2003); Ability to hear but not respond during a blackout (Avbersek & 148 
Sisodiya 2010); Pre-ictal dissociative symptoms (Stone 2006); Postictal crying/upset 149 
(Alessi et al. 2013). 150 
- Weakness: Dropping things frequently; Variable severity; Worsening of weakness with 151 
attention (Pareés et al. 2013); Prodromal anxiety (Pareés et al. 2014; Stone, Alan Carson, 152 
et al. 2009); Associated depersonalisation (Stone et al. 2012); 153 
- Memory Problems: Forgetting important details of everyday life(Schmidtke & 154 
Metternich 2009); Blank spells occurring during the day (Schmidtke & Metternich 2009); 155 
Oneself more bothered than others; 156 
- Tremor: Sudden onset (Kenney et al. 2007); Precipitating traumatic event (Pareés et al. 157 
2014); Variable severity (Kenney et al. 2007); Distractibility (Roper et al. 2013). 158 
- Pain: Variable location and severity (Baker & Shaw 2007). 159 
- Fatigue: Worsened by activity (Baker & Shaw 2007). 160 
Patients only had to complete sub-questions regarding a symptom if they had reported 161 
ĞǆƉĞƌŝĞŶĐŝŶŐƚŚĞƐǇŵƉƚŽŵĂƐĂ “ƐƚĞŵ ?ƋƵĞƐƚŝŽŶ ? 162 
 163 
We also included questions about the presence of certain symptoms and features of 164 
clinical history that in themselves may be predictive of a functional disorder. These included 165 
hemisensory syndrome ( ‘Do you have numbness or altered sensation that makes you feel 166 
like your body is cut in half? ?) (Toth 2003), globus (Finkenbine & Miele 2004), stutter 167 
(Baumgartner & Duffy 1997; Duffy 2016), multiple medical problems (McGorm et al. 2010), 168 
and particular operations such as hysterectomy, appendicectomy, laparoscopy or 169 
tonsillectomy (Fink 1992; Longstreth & Yao 2004). These items did not have differentiating 170 
sub-questions. Demographic data including sex and age were also collected. 171 
 172 
Diagnosis and Rating of explanation with respect to functional disorder 173 
We asked neurologists to provide 1) their provisional diagnosis and 2) their assessment of 174 
the extent to which the patients ? symptoms were related to a functional disorder. 175 
Functional neurological and somatic disorders remain a taxonomic challenge and often exist 176 
in a spectrum, concomitant with structural disease. For this reason, patients were scored 177 
according to a 4-ƉŽŝŶƚ>ŝŬĞƌƚƐĐĂůĞ P ‘EŽƚĂƚůů ? ? ‘^ŽŵĞǁŚĂƚ ? ? ‘>ĂƌŐĞůǇ ?ĂŶĚ ‘ŽŵƉůĞƚĞůǇ ?ďǇ178 
ĐůŝŶŝĐŝĂŶƐŝŶƌĞƐƉŽŶƐĞƚŽƚŚĞƋƵĞƐƚŝŽŶ P “dŽǁŚĂƚĞǆƚĞŶƚĚŽǇŽƵƚŚŝŶŬƚŚĞƉĂƚŝĞŶƚ ?ƐĐůŝŶŝĐĂů179 
symptoms are explained by a functional disoƌĚĞƌ ? ? ?ĞĨŝŶŝƚŝŽŶƐŽĨĨƵŶĐƚŝŽŶĂůĚŝƐŽƌĚĞƌƐǁĞƌĞ180 
supplied to clinicians as a guide to diagnostic category (Appendix 2). A graded classification 181 
like this allows for a broader evaluation of patients which may have symptoms without a 182 
structural cause but not a primary functional diagnosis. Note this question was an evolution 183 
of previous categorisations from our research group as 'not explained by disease' (Stone, A. 184 
Carson, et al. 2009). We were keen to move away from defining disorders by the absence of 185 
disease since they have their own positive diagnostic features, now recognised in DSM-5 186 
criteria for Functional Neurological Symptom Disorder. 187 
 188 
Questionnaire Analysis 189 
&ŽƌƚŚĞƉƵƌƉŽƐĞƐŽĨĂŶĂůǇƐŝƐƉĂƚŝĞŶƚƐǁĞƌĞŐƌŽƵƉĞĚŝŶƚŽŚĂǀŝŶŐƐǇŵƉƚŽŵƐĐůĂƐƐĞĚĂƐ ‘EŽƚĂƚ190 
Ăůů ?^ŽŵĞǁŚĂƚ ?ĂŶĚ ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ?ĚƵĞƚŽĂĨƵŶĐƚŝŽ ĂůĚŝƐŽƌĚĞƌ ?Univariate analysis 191 
was undertaken on individual questions by cross-tabulation and significance testing using 192 
&ŝƐŚĞƌ ?ƐǆĂĐƚ test. Symptom and gross ENS score were assessed using two-ƚĂŝůĞĚ^ƚƵĚĞŶƚ ?Ɛ193 
T tests. Multivariate analysis was undertaken via logistic regression. We first analysed the 194 
diagnostic utility of sub-ƋƵĞƐƚŝŽŶƐŝŶƉƌĞĚŝĐƚŝŶŐĐůĂƐƐŝĨŝĐĂƚŝŽŶŽĨ ‘>ĂƌŐĞůǇ ?Žƌ ‘ŽŵƉůĞƚĞůǇ ?195 
functional for reporters of a particular symptom. Linear models for each symptom were 196 
used to return a score for likelihood of functional classification. Scores from these 197 
symptoms were then combined in an aggregate model with symptoms and features that did 198 
not have sub-questions and demographic data to provide an overall score. This method 199 
introduces a significant positive bias into the second round of modelling, as symptoms with 200 
sub-questions have already been weighted towards predicting a functional outcome. 201 
Alternative options such as hierarchical logistic regression and stratifying patients by 202 
reported symptoms were prohibited by sample size and the number of potential symptom 203 
combinations. We justify this method as exploratory and speculative in the context of a pilot 204 
that aims to obtain a broad picture of the potential utility of a general screening tool. 205 
Questions which provided perfect or quasi-separation were excluded from multivariate 206 
analysis and their contribution assessed during univariate analysis only. All analysis was 207 
conducted in MATLAB© Release 2015b using custom written scripts. 208 
Results 209 
Data were gathered on 165 patients, 56 (34%) participants had data missing and were 210 
excluded leaving 109 (Age = 44.6 ± 17.1 years; Female:Male Ratio = 1.53:1) responses 211 
available for analysis. 104/109 (95%) of those surveyed responded having at least one of the 212 
symptoms included in the questionnaire. 213 
 214 
73/109 (67%) patients were clasƐĞĚĂƐŚĂǀŝŶŐƐǇŵƉƚŽŵƐ ‘EŽƚĂƚůů ?^ŽŵĞǁŚĂƚ ?E ?^ ? ?215 
and 36/109  ? ? ?A? ?ĂƐ ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ?> ? ? ?ĚƵĞƚŽĂĨƵŶĐƚŝŽŶůdisorder. The most 216 
ĐŽŵŵŽŶĚŝĂŐŶŽƐĞƐŵĂĚĞŝŶƚŚŽƐĞĐůĂƐƐŝĨŝĞĚĂƐ ‘EŽƚĂƚůů ?^ŽŵĞǁŚĂƚ ?ǁĞƌĞ PƉŝůĞƉƐǇ ? ? ?109 217 
(15%), Migraine 11/109 (10%), peripheral neuropathy or radiculopathy 9/109 (8%), 218 
headache syndromes 6/109 (6%), first seizure 6/109 (6%) and demyelinating disease 5/109 219 
(5%) ?/ŶƚŚŽƐĞĐůĂƐƐŝĨŝĞĚĂƐ ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ? P dissociative seizures 9/109 (8%), functional 220 
weakness 3/109 (3%), functional sensory changes 3/109 (3%), anxiety related symptoms 221 
3/109 (3%), functional memory symptoms 1/19 (1%) and FND not otherwise specified 2/109 222 
(2%) were the most common diagnoses.  Female:Male ratio differed significantly between 223 
ŐƌŽƵƉƐ ?E ?^A? ? ? ? ? P ? ?> ?A? ? ? ? P ? ?&ŝƐŚĞƌ ?ƐǆĂĐƚƉA? ? ?  ? ? ? ?ǁŚŝůƐƚĂŐĞĚŝĚŶŽƚ ?E ?^A? ? ?± 224 
17.5; L/C = 41.6 ± 16.2; two-tĂŝůĞĚ^ƚƵĚĞŶƚ ?ƐdƉA? ? ? ? ? ?225 
 226 
The 56 participants excluded from analysis due to incomplete questionnaires or 227 
consultant diagnosis were marginally older than those included (47.15 ± 17.1 vs 44.6 ± 16.83 228 
years ?^ƚƵĚĞŶƚ ?Ɛƚ-Test p = 0.36) and had a greater F:M ratio (2.31:1 vs 1.53:1; Chi-square p = 229 
0.72). 15/56 were excluded for lack of diagnosis outcome data, of those remaining 28/41 230 
 ? ? ?A? ?ǁĞƌĞĐůĂƐƐĞĚĂƐŚĂǀŝŶŐƐǇŵƉƚŽŵƐ ‘EŽƚĂƚĂůů ?^ŽŵĞǁŚĂƚ ?ĚƵĞƚŽĂĨƵŶĐƚŝŽŶĂůĚŝƐŽƌĚĞƌ231 
and 13/41 (32%), similar proportions to those included in analysis (Chi-Square p = 0.88). 232 
 233 
Univariate Analysis: Few questions provide diagnostic utility and gross scores fail to 234 
discriminate patients. 235 
Answers to all symptom questions and sub-questions are displayed in Table 1. Some 236 
symptoms were reported significantly more frequently by those classed as 237 
 ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ?ĨƵŶĐƚŝŽnal, including: hemisensory disturbance (N/S = 8/73 (11%); L/C 238 
= 11/36 (31%); p = 0.016), tremor (N/S = 19/73 (11%); L/C = 17/36 (31%); p = 0.016), pain 239 
(N/S = 24/73 (33%); L/C = 22/36 (61%); p = 0.007), fatigue (N/S = 40/73 (55%); L/C = 28/36 240 
(78%); p = 0.022). 241 
 242 
5/20 symptom features were reported significantly more often by patients classed as 243 
 ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ? related to a functional disorder including: having had a blackout in a 244 
medical setting (N/S = 1/21 (5%); L/C = 5/9 (56%); p = 0.005); being able to hear others but 245 
not respond during a blackout (N/S = 5/21 (24%); L/C = 8/9 (89%); p = 0.002); crying or being 246 
upset after a blackout (N/S = 5/21 (24%); L/C = 6/9 (67%); p = 0.042); having blank spells 247 
occurring throughout the day if also experiencing memory problems (N/S = 12/39 (31%); L/C 248 
= 15/22 (68%); p = 0.007) and experiencing pain that is variable in severity and location (N/S 249 
= 10/24 (42%); L/C = 16/22 (73%); p = 0.042). 250 
 251 
Gross symptom count ǁĂƐƐŝŐŶŝĨŝĐĂŶƚůǇĚŝĨĨĞƌĞŶƚďĞƚǁĞĞŶ ‘E ?^ ?ĂŶĚ ‘> ? ?ƉĂtients 252 
(N/S = 3.15 ± 2.07; L/C = 4.33 ± 2.27; 2-dĂŝůĞĚ^ƚƵĚĞŶƚ ?ƐdƉA? ? ? ? ? ? ?(Figure 1A) but without 253 
diagnostic utility (Receiver-operator characteristic area under the curve (AUC) = 0.595). Raw 254 
Edinburgh Neurosymptom Score (ENS) scores, which include the addition of sub-questions 255 
designed to provide a positively discriminating score, yields greater grŽƐƐƐĐŽƌĞƐĨŽƌ ‘> ? ?256 
patients, again significantly so (N/S = 7.95 ± 5.48; L/C = 11.69 ± 7.27; 2-dĂŝůĞĚ^ƚƵĚĞŶƚ ?ƐdƉA?257 
0.003) (Figure 1B) but again without diagnostic utility (AUC = 0.602).  258 
 259 
Multivariate sub-question analysis: Blackouts may be amenable to questionnaire 260 
diagnosis, but other symptom groups lack discriminating questions. 261 
>ŽŐŝƐƚŝĐƌĞŐƌĞƐƐŝŽŶĂŶĂůǇƐŝƐŽĨŝŶĚŝǀŝĚƵĂů “ĐŽŵŵŽŶ ?ƐǇŵƉƚŽŵƐŝƐĚĞƐĐƌŝďĞĚŝn Figure 2. Only 262 
three sub questions obtained significance during multivariate ĂŶĂůǇƐŝƐ ?Y ?Ě P “,ĂǀĞǇŽƵĞǀĞƌ263 
ďĞĞŶĂďůĞƚŽŚĞĂƌƉĞŽƉůĞďƵƚŶŽƚƌĞƐƉŽŶĚƚŽƚŚĞŵĚƵƌŝŶŐǇŽƵƌďůĂĐŬŽƵƚ ? ?(p = 0.047; OR = 264 
20.72 (0.88-487.97) ? ?Y ?Đ P “ŽǇŽƵŚĂǀĞďůĂŶŬƐƉĞůůƐǁŚŝĐŚ ŽĐĐƵƌĚƵƌŝŶŐƚŚĞĚĂǇ ? ? ?ƉA?265 
0.019; OR = 4.066 (1.23-13.45) ? ?ĂŶĚY ?Ă P “/ƐǇŽƵƌƉĂŝŶǁŽƌƐĞŝŶĚŝĨĨĞƌĞŶƚƉĂƌƚƐŽĨǇŽƵƌďŽĚǇ266 
ŽŶĚŝĨĨĞƌĞŶƚĚĂǇƐ ? ? ?ƉA? ? ? ? ? ? ?KZA? ? ? ? ? (1.04-13.37)). Diagnostic utility (AUC) of sub-267 
questions for each symptom were: blackouts = 0.94, weakness = 0.71, memory problems = 268 
0.74, tremor = 0.63, pain = 0.66 and fatigue = 0.6.  269 
 270 
Aggregate symptom score modestly predicts functional classification. 271 
Scores from symptom sub-question modelling were input into an aggregate model with 272 
other symptoms, features of clinical history, sex and age. Variable coefficients for the 273 
resulting model are shown in Figure 3. Only adjusted pain score (p = 0.047) and adjusted 274 
blackout score (p = 0.021) achieved significance in the model, with odds ratios 26.80 (2.00-275 
359.59) and 40.15 (1.73-930.21) respectively. 276 
 277 
Resulting aggregate scores were capable of predicting functional disorder likelihood 278 
with modest utility (Figure 4) (AUC = 0.83) and  “optimal ? operating point, as determined by 279 
minimising false positive rate, resulting in specificity and sensitivity of 0.99 and 0.47 280 
respectively. Positive and negative predictive values were 0.94 and 0.79. The model 281 
accounted for little of the variability in the outcome (Adjusted R2 = 0.23) but performed 282 
better than the constant model (Chi-squared Test vs Constant model p < 0.001). 283 
 284 
Symptom  ?ŶĞƚǁŽƌŬƐ ?ŵĂǇĂŝĚŝŶĚŝĨĨĞƌĞŶƚŝĂƚŝŶŐĨƵŶĐƚŝŽŶĂůƉĂƚŝĞŶƚƐ ? 285 
We also investigated whether symptom combinations or interactions may provide insight 286 
into functional vs structural questionnaire responses. Inclusion of interaction terms in 287 
regression analysis was prohibited by sample size therefore conditional probabilities 288 
between symptom pairs were computed instead. Of the 110 possible bidirectional symptom 289 
pairings, patients ĐůĂƐƐĞĚĂƐ ‘>Ărgely/ComplĞƚĞůǇ ?ĨƵŶĐƚŝŽŶĂů were more likely to report one 290 
ƐǇŵƉƚŽŵĂĨƚĞƌƌĞƉŽƌƚŝŶŐĂŶŽƚŚĞƌǁŚĞŶĐŽŵƉĂƌĞĚƚŽƚŚŽƐĞĐůĂƐƐĞĚĂƐ ‘EŽƚĂƚůů ?^ŽŵĞǁŚĂƚ ?291 
in 76/110 pairings. Figure 5 exhibits how fatigue plays a central role in these interactions, 292 
being reported by more than 80% of those also reporting: stutter, memory problems, pain, 293 
weakness, blackouts, globus, altered sensation, tremor and multiple medical problems. Only 294 
one symptom pair (P(Memory problems | Multiple medical problems)) reaches this 295 
threshold in those with symptoms not explained by a functional disorder and none do so 296 
when paired with fatigue. 297 
Discussion 298 
This is the first reported pilot of a general screening questionnaire to improve the pre-test 299 
probability of a diagnosis functional neurological disorders. We find that gross number of 300 
symptoms, in the subset we investigate here, failed to distinguish cases from controls. 301 
Addition of items in our novel questionnaire about features reportedly specific to functional 302 
disorders also commonly failed to distinguish patient groups in our sample. We found some 303 
exceptions, where patients classified as having functional symptoms more commonly 304 
reported features of: Blackouts (having had a blackout in a medical setting, being able to 305 
hear people but not respond during a blackout, being upset following an episode); Memory 306 
problems (having associated blank spells during the day); Pain (reporting variability in bodily 307 
location and severity. 308 
 309 
Symptoms scores weighted according to these features in an aggregate model show 310 
good specificity (0.99) but poor sensitivity (0.47) when compared to consultant neurologist 311 
impression as measured on a 4-point Likert scale. Resulting positive and negative predictive 312 
values (0.94 and 0.79 respectively) were however, promising, and had greater utility as a 313 
pre-screening diagnostic tool for FND than measures based on symptom counts such as 314 
PHQ-15 (Carson et al. 2014; Van Ravesteijn et al. 2009). Although effective for excluding 315 
those deemed to have symptoms of an  “ŽƌŐĂŶŝĐ ?ĐĂƵƐĞ, our linear score failed to reliably 316 
identify patients with FND from a general neurology outpatient population. Our speculative 317 
assessment of symptom interactions suggests that non-linear methods that take account of 318 
multivariate higher order interactions may prove a more valuable approach.  319 
 320 
Eliciting self-reported positive features of functional disorders is challenging. 321 
Although many discriminating features of history have been described in the literature and 322 
anecdotally, our data show that these are difficult to translate into specific and sensitive 323 
questions for patients to answer in an unguided way. The corollary being that although our 324 
understanding of the semiology and history of functional symptoms has improved, the 325 
ability to extract that from patients in a meaningful way is still the remit of an experienced 326 
diagnostic interview and physical examination. 327 
 328 
Capturing the recognised linguistic features of FND descriptions is a core problem in 329 
constructing a viable self-reported screening questionnaire. There is now a significant body 330 
of work highlighting these discriminating features: Poor formulation effort (Schwabe et al. 331 
2008), inconsistent metaphorical conceptualisation (Plug et al. 2009), and vague seizure 332 
experience descriptions in psychogenic non-epileptic seizures; preserved working memory, 333 
the ability to process compound questions and good recollection of personal information in 334 
functional memory disorders (Jones et al. 2016); post-exertional malaise in fatigue (Keech et 335 
al. 2015). However, those studies were all done on the basis of interactive conversation 336 
analysis. Self-report tools implicitly rely on a particular symptom being amenable to self-337 
recognition. Transposing clinical observations into questions capable of eliciting 338 
ŝŶƚƌŽƐƉĞĐƚŝŽŶĂŶĚ ‘ĂĐĐƵƌĂƚĞ ?ƌĞƐƉŽŶƐĞŝƐa clear limitation to such an enquiry. It may be that 339 
questionnaire items need to be refined or that questionnaires are, themselves, too crude a 340 
tool.  341 
 342 
Perhaps a surprising finding in this population is that questions regarding functional 343 
symptoms such as globus and stutter show poor diagnostic utility in both univariate and 344 
multivariate analysis. Although globus and adult onset stutter are generally considered to 345 
relate to a functional disorder they were reported with similar frequency in both functional 346 
and non-functional groups, albeit in small numbers. There were also interesting responses 347 
in those with symptoms unexplained by a functional disorder to questions that are 348 
commonly associated with functional disorders. For example, 8 out of 73 patients reported 349 
ƚŚĂƚƚŚĞǇŚĂĚŶƵŵďŶĞƐƐŽƌĂůƚĞƌĞĚƐĞŶƐĂƚŝŽŶƚŚĂƚŵĂĚĞƚŚĞŵĨĞĞů ‘ůŝŬĞǇŽƵƌďŽĚǇŝƐĐƵƚŝŶ350 
ŚĂůĨ ? (Toth 2003) and 5 out of 21 patients reported tearfulness after blackouts (Avbersek & 351 
Sisodiya 2010). Questions about movement disorders also indicated the difficulty of using 352 
questionnaires to elicit a history. All 19 patients who reported an abnormal movement such 353 
as tremor in the structural group said it came on suddenly. But what a neurologist 354 
understands as sudden, e.g. not there at 10.58am and present at 11.00am  ? may not be the 355 
same as how a patient understands that word  ? e.g. /ĚŝĚŶ ?ƚŚĂǀĞŝƚůĂƐƚ year and suddenly 356 
this year I do. It was also surprising how many movement disorder patients said that their 357 
movements could go away for hours or days (16/19). 358 
 359 
The importance of diagnostic tools and more effective diagnostic procedures in FNDs 360 
A standardised and easily administrable tool for the screening of functional disorders has 361 
the potential to enhance clinicians ? pre-test probability for making a diagnosis of functional 362 
disorder and, as a consequence of earlier intervention, reduce iatrogenic harm. A shorter 363 
duration of symptoms prior to diagnosis often predicts a favourable prognosis in FNDs 364 
(Gelauff et al. 2014; Sharpe et al. 2010a). Early identification of patients with likely 365 
functional symptoms could also assist in quantifying their prevalence and demographics at 366 
an epidemiological scale. So far this has been unattainable with the present non-specific 367 
tools and the expense of definitive clinical diagnosis. 368 
 369 
Limitations 370 
This was a pilot study of a new approach to FND diagnosis, with a relatively small sample 371 
size. Our reported predictive values are dependent on prevalence calculated on a relatively 372 
small population which, for certain symptoms, failed to meet the generally accepted rule of 373 
5-10 participants per predictor variable (Kupper & Hafner 1989). The large variances 374 
observed during linear modelling may be a reflection of this, or a reflection of the variable 375 
nature of functional disorders. There is a risk that some patients were classified in to the 376 
wrong diagnostic group by the neurologists seeing them, although a similar study found a 377 
very low rate of misdiagnosis at 18 months follow up (Stone, A. Carson, et al. 2009). We also 378 
ĚŽŶ ?ƚŬŶŽǁǁŚĞƚŚĞƌ ?ĞǀĞŶŝĨƚŚĞneurologist rated the main diagnosis as  “ŽƌŐĂŶŝĐ ?, the 379 
symptom the patient gave their responses about would have received the same rating. We 380 
are also cautious to highlight the limitations of the present two-stage modelling. Ideally, 381 
sub-question coefficients should be computed on a separate population from the overall 382 
aggregate score to prevent a significant bias in favour of symptoms with sub-questions in 383 
the final model. 384 
 385 
Our final model is biased to a degree by case deletion of those with incomplete 386 
questionnaires. 109 individuals were included in the final analysis, with 56 (34%) of the 165 387 
participants excluded. Given this significant proportion we sought to establish whether their 388 
inclusion in analysis might mitigate some of the bias case deletion introduces. Given that we 389 
first model symptom sub-questions on a subset of those reporting that symptom, we sought 390 
to include every participant who had at least answered a single symptom ?ƐƐƵď-questions 391 
completely in the first stage of modelling. Using symptom scores derived from this more 392 
inclusive criterion, we then reran the aggregate model with the 109 respondents who had 393 
complete questionnaires. Resulting sub-question coefficients were similar with Q1d:  “,ĂǀĞ394 
you ever been able to hear people but not respond ƚŽƚŚĞŵĚƵƌŝŶŐǇŽƵƌďůĂĐŬŽƵƚ ? ?ĂŶĚ395 
Y ?Đ P “ŽǇŽƵŚĂǀĞďůĂŶŬƐƉĞůůs which occur during ƚŚĞĚĂǇ ? ?ƌĞŵĂŝŶŝŶŐƐŝŐŶŝĨŝĐĂŶƚǁŝƚŚƉ396 
ǀĂůƵĞƐŝŶƚŚĞŶĞǁŵŽĚĞů ? ? ? ? ?ĂŶĚ ? ? ? ? ?ƌĞƐƉĞĐƚŝǀĞůǇ ?ŶĚY ?Ă P “/ƐǇŽƵƌƉĂŝŶǁŽƌƐĞŝŶ 397 
ĚŝĨĨĞƌĞŶƚƉĂƌƚƐŽĨǇŽƵƌďŽĚǇŽŶĚŝĨĨĞƌĞŶƚĚĂǇƐ ? ?ďĞĐŽŵŝŶŐůĞƐƐƐŝŐŶŝĨŝĐĂŶƚ ?ƉA? 0.052).  In the 398 
final aggregate model, blackout scores become insignificant (OR = 7.97 (0.57-111.68)) but 399 
pain scores remain predictive (OR = 21.87 (1.34-358.05). Aggregate scores however retain 400 
similar discriminate utility (AUC = 0.80) and sensitivity of 0.64 and specificity of 0.84 at the 401 
 ‘ŽƉƚŝŵĂů ?ŽƉĞƌĂƚŝŶŐƉŽŝŶƚ ? 402 
 403 
We also found that many of our questions, or question wordings, although 404 
constructed to elicit positive answers in those experiencing functional symptoms, failed to 405 
do so on many occasions. Only blackouts, memory problems and pain domains had sub-406 
ƋƵĞƐƚŝŽŶƐĂŶƐǁĞƌĞĚƐŝŐŶŝĨŝĐĂŶƚůǇŵŽƌĞŽĨƚĞŶďǇƉĂƚŝĞŶƚƐĚĞĞŵĞĚ ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ?407 
functional. The heterogeneity of both FND and neurological pathology in general may be the 408 
limiting factor to such a broad goal. It is clear that if the present tool is to be developed, and 409 
sensitivities greater than 0.47 are to be achieved, question wording and inclusion needs to 410 
be adjusted considerably.  411 
 412 
ZĞĂĚĞƌƐŵĂǇĂůƐŽǁŽŶĚĞƌǁŚǇǁĞĚŝĚŶ ?ƚƐƚƵĚǇƚŚĞƉĞƌĨŽƌŵĂŶĐĞŽĨƚŚĞƌĞůĞǀĂŶƚ413 
subsections of the questionnaire for diagnostic categories (e.g. functional gait disorder, non-414 
epileptic seizures). This was firstly because the numbers involved would have been too small 415 
and secondly because patients with functional neurological disorders often have mixed 416 
symptoms which are not always picked up on diagnostically by neurologists.  417 
 418 
Conclusions 419 
Despite limitations, this pilot version of an ENS questionnaire was, in its complete form, 420 
surprisingly capable of reliably excluding patients diagnosed by neurologists as not having a 421 
functional disorder. It was capable of including a significant number of functional patients, 422 
particularly those that report blackouts, memory problems and pain. The use of specific 423 
positive features of functional disorder in an aggregate model rather than linear summation 424 
of symptom counts has shown promising utility. Future work could aim to investigate more 425 
systematically how those who experience functional symptoms, outside the domain of 426 
blackouts, report their disorder and therefore how to improve the questions or wording in 427 
later versions of this questionnaire. 428 
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Table 1 433 
 434 
Q11: Have you needed any operations? 0.41516/36 (44%)40/73 (55%)
Q10: Do you have a stutter which started after you were more than 16 years old? 0.6823/36 (8%)4/73 (5%)
Q9: Do you get a feeling that there is a lump in your throat or something stuck when
you are trying to eat or drink?
1.0008/36 (22%)18/73 (25%)
0.53316/36 (44%)27/73 (37%)
Q8: In the last five years have you had to see doctors in the hospital for different
problems more than four times? (E.g. problems with your heart, your joints, your
brain and gut)
Q7: Have you been lacking energy every day or almost every day for the last six
months?
0.022*28/36 (78%)40/73 (55%)
Q7a: Does activity make your fatigue worse? 0.10723/28 (82%)25/40 (63%)
Q6: During the last three months have you had pain almost every day in more than
one part of your body?
0.007**22/36 (61%)24/73 (33%)
Q6a: Is your pain worst in different parts of your body on different days? 0.042*16/22 (73%)10/24 (42%)
0.032*17/36 (47%)19/73 (26%)
Q5: During the last six months have you been bothered by tremor or an abnormal
movement in one or more limb e.g. arm (s) or leg(s)?
0.21615/17 (88%)19/19 (100%)Q5a: Did your tremor or abnormal movement come on suddenly?
0.6503/17 (18%)2/19 (11%)
Q5b: Did your tremor or abnormal movement come on after an injury or
accident?
0.60516/17 (94%)16/19 (84%)
Q5c: Can your tremor or abnormal movement go away completely for hours
to days only to return again?
0.4345/17 (29%)3/19 (16%)
Q5d: Does your tremor or abnormal movement ever stop when you are
distracted or concentrating on something else?
Q4: During the last six months have you been bothered by memory problems? 0.54022/36 (61%)39/73 (53%)
Q4a: Who is most bothered by your memory problems, you or your
partner/family/friends?
Family: 3/39 (8%)
Me: 32/39 (82%)
Unsure: 4/39 (10%)
Family: 4/22 (18%)
Me: 16/22 (73%)
Unsure: 2/22 (9%)
0.467
Q4b: Are you bothered by forgetting important details such as the name of a
family member or your PIN number?
0.18414/22 (64%)17/39 (44%)
Q4c: Do you have blank spells which occur during the day? 0.007**15/22 (68%)12/39 (31%)
Q3: Do you have numbness or altered sensation that makes you feel like your body
is cut in half?
0.016*11/36 (31%)8/73 (11%)
0.22020/36 (56%)30/73 (41%)
Q2: During the last six months have you been bothered by weakness in one or more
limb e.g. arm(s) or leg(s)?
0.15913/20 (65%)13/30 (43%)Q2a: Do you drop things frequently?
1.00010/20 (50%)14/30 (47%)Q2b: Does your limb weakness get worse or better at different times of the
day?
0.1149/20 (45%)6/30 (20%)Q2c: Does concentrating on trying to move make the limb weakness worse?
0.23510/20 (50%)9/30 (30%)
Q2d: At the start of your limb weakness did you feel your heart pounding or
did you feel frightened, anxious or very uneasy?
0.56511/20 (55%)13/30 (43%)Q2e: Does your weak limb feel like it does not fully belong to you?
Q1: During the last 6 months have you been bothered by blackouts? 0.8309/36 (25%)21/73 (29%)
Lie Still: 5/21 (24%)
Shake: 13/21 (62%)
Unsure: 3/21 (14%)
Lie Still: 3/9 (33%)
Shake: 4/9 (44%)
Unsure: 2/9 (22%)
0.673Q1a: During you blackouts do you get told you lie still or shake?
0.005**5/9 (56%)1/21 (5%)
Q1b: Have you ever had a blackout in a medical setting e.g. visiting the
hospital/GP/another doctor?
0.5632/9 (22%)2/21 (10%)
Q1c: Have you had more than two seizures during which you shook without
stopping for more than 10 minutes? (This does not include the time taken for you
to come round after the seizure had finished)
0.002**8/9 (89%)5/21 (24%)
Q1d: Have you ever been able to hear people but could not respond to them
during your blackout?
0.0679/9 (100%)13/21 (62%)
Q1e: Do you ever have moments before your blackouts of losing track of what is
going on, of  “blanking out ?or  “spacing out ?or in some way feeling that you are
not part of what is going on?
0.042*6/9 (67%)5/21 (24%)Q1f: Are you told that after an attack you cry or are upset?
N 36/109 (33%)73/109 (67%)
0.01**Sex F:M = 3.5:1F:M = 1.09:1
Age ( Mean ц SD) 0.20041.6 A?16.246 A?17.5
Symptom Count ( Mean ц SD) 0.008**3.15 A?2.07 4.33 A?2.27
Gross ENS Score ( Mean ц SD) 0.003**7.95 A?5.48 11.69 A?7.27
p-valueLargely/CompletelyNot at All/Somewhat
Symptoms explained by a func೦onal disorder:
Figure 1 435 
 436 
Figure 1: Comparison of gross scores. A - Boxplot of symptom counts separated by 437 
functional classification. Symptom counts are significantly greater in patients with functional 438 
disorder. B - Boxplot of gross scores for full 30-point ENS questionnaire. The addition of 439 
discriminating sub-ƋƵĞƐƚŝŽŶƐǇŝĞůĚƐŐƌĞĂƚĞƌƐĐŽƌĞƐĨŽƌ ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚůǇ ?explained by 440 
functional disorder. C - ROC curve of symptom count and gross sum. Symptom count and 441 
raw ENS scores fail to provide diagnostic utility (N/S = Not at All/Somewhat; L/C = 442 
Largely/Completely explained by a functional disorder). 443 
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Figure 2 454 
 455 
Figure 2: Results of multivariate sub-question analysis. Sub-questions were input as 456 
predictor variables and the resulting coefficients, confidence intervals and odds ratios are 457 
displayed above. Only Q1d, Q4c and Q6a achieve significance in their respective models. 458 
Most sub-questions provide, as expected, a positive predictive value for functional 459 
classification, but only 3 did so with odds ratios significantly greater than 1. 460 
 461 
 462 
 463 
 464 
 465 
Figure 3466 
 467 
Figure 3: Aggregate score coefficients. Forest plot showing linear coefficients and 468 
ĐŽŶĨŝĚĞŶĐĞŝŶƚĞƌǀĂůƐĨŽƌĞĂĐŚǀĂƌŝĂďůĞŝŶƚŚĞĂŐŐƌĞŐĂƚĞŵŽĚĞů ? “ŽŵŵŽŶ ?ƐǇŵƉƚŽŵƐŚĂǀĞ469 
been replaced by the linear predictor scores from sub-question modelling. Odds ratios are 470 
displayed for each coefficient above the bar. Adjusted scores for pain and blackouts achieve 471 
significance and drastically increase the odds of correct classification. 472 
 473 
Figure 4 474 
 475 
Figure 4: Diagnostic utility of the ENS questionnaire. A - ROC curve of aggregate linear 476 
model scores ƉƌĞĚŝĐƚŝŶŐĐŽŶƐƵůƚĂŶƚĐůĂƐƐŝĨŝĐĂƚŝŽŶŽĨƉĂƚŝĞŶƚƐǁŝƚŚƐǇŵƉƚŽŵƐ ‘EŽƚĂƚ477 
ůů ?^ŽŵĞǁŚĂƚ ?Žƌ ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ?ĨƵŶĐƚŝŽŶĂů. The optimal operating point is displayed 478 
as a red circle on the curve. Predictor scores were capable of achieving an AUC of 0.83. B - 479 
Scatter plot of aggregate model scores separated by functional classification. The 480 
corresponding optimal score identified in ROC analysis is displayed as a grey dotted line. The 481 
model is capable of excluding non-functional patients effectively, but many functional 482 
patients are missed with the  ‘ŽƉƚŝŵĂů ?threshold. 483 
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 493 
Figure 5 494 
 495 
 496 
Figure 5: Symptom interactions. Paired conditional probabilities of symptoms occurring if 497 
another symptom is reported. Red lines indicate a symptom pair in which there is a more 498 
than 80% likelihood of a co-occurrence. Grey lines indicate co-occurrence > 0.5 and are 499 
weighted linearly between 0.5-0.8. Patients with functional disorders reported symptom 500 
networks that are far more connected than structural patients. Fatigue plays a central role 501 
ŝŶƚŚĞǀŝƐŝďůĞĚŝĨĨĞƌĞŶĐĞƐ ? ?ZĞĚ P&ƵŶĐƚŝŽŶĂůĐůĂƐƐA? ‘>ĂƌŐĞůǇ ?ŽŵƉůĞƚĞůǇ ? ?ůƵĞ P&ƵŶĐƚŝŽŶĂů502 
class =  ‘EŽƚĂƚůů ?^ŽŵĞǁŚĂƚ ? ? ?503 
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